LINC01410 can inhibit miR-532-5p expression, while silencing miR-532-5p reduces inhibition of NCF2, thus upregulating NCF2 expression and activating the NF-κB signaling pathway, exacerbating malignant progression and angiogenesis of gastric cancer. This evidence concerns the gene NCF2 and gastric cancer.